ContractMorphic Holding, Inc. • April 12th, 2019 • Pharmaceutical preparations • California
THIS WARRANT AND THE UNITS ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AS SET FORTH IN SECTIONS 5.3 AND 5.4 BELOW, MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND LAWS OR, IN THE OPINION OF LEGAL COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE ISSUER, SUCH OFFER, SALE, PLEDGE OR OTHER TRANSFER IS EXEMPT FROM SUCH REGISTRATION.
CONSULTING AGREEMENT (Timothy A. Springer, Ph.D.)Consulting Agreement • April 12th, 2019 • Morphic Holding, Inc. • Pharmaceutical preparations • Massachusetts
This Consulting Agreement (this “Agreement”) is made effective as of June 1, 2015. In consideration for retaining Timothy A. Springer, Ph.D. (“Consultant”) by Morphic Rock Holding, LLC, f/k/a Integrin Rock, LLC (the “Company”), a Delaware limited liability company. For good and valuable consideration, the parties hereby agree as follows:
INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • April 12th, 2019 • Morphic Holding, Inc. • Pharmaceutical preparations • Delaware
THIS INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of the 5th day of December, 2018, by and among Morphic Holding, Inc., a Delaware corporation (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor.”
